PLK4 and brain neoplasm: In conclusion, we showed that PLK4 can be inhibited by a variety of structurally disparate molecules, with varying degrees of in vitro phenotypic effects and that a selective PLK4i with favorable physiochemical properties for optimal brain exposure will be beneficial for the treatment of aggressive brain tumors with PLK4 overexpression.